Key Insights
- Significant control over Shanghai Pharmaceuticals Holding by retail investors implies that the general public has more power to influence management and governance-related decisions
- A total of 4 investors have a majority stake in the company with 51% ownership
- Institutions own 15% of Shanghai Pharmaceuticals Holding
If you want to know who really controls Shanghai Pharmaceuticals Holding Co., Ltd (SHSE:601607), then you’ll have to look at the makeup of its share registry. And the group that holds the biggest piece of the pie are retail investors with 35% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company.
And last week, retail investors endured the biggest losses as the stock fell by 4.4%.
Let’s take a closer look to see what the different types of shareholders can tell us about Shanghai Pharmaceuticals Holding.
